DUBAI, UAE, Jan. 26,
2025 /CNW/ -- On the eve of the Arab
Health Exhibition, Yuwell Medical held its 2025 Global Core
Partner Conference in Dubai, and announced a strategic
investment and partnership with Inogen, a leading U.S. company
in respiratory health, highlighting our joint commitment to
advancing medical device solutions and deeper collaboration.
Speaking at the Yuwell Medical 2025 Global Core Partner
Conference, Alex WU, Chairman of Yuwell Medical, stated that as a
leading enterprise in China's home
medical device industry, Yuwell will rely on internal growth and
external mergers and acquisitions to promote internationalisation.
The company has updated its new vision for the next five years: to
become top three companies in the global home medical health market
in the mid-to-long term. Among them, respiratory treatment
solutions, diabetes care, and emergency service solutions are the
three key strategic sectors. The company will further strengthen
its globalization strategy from three aspects: organizational
structure expansion, recruitment of outstanding overseas talents
product R&D innovation, and supply chain integration
innovation.
He further emphasized, "In the process of realizing the new
vision, Yuwell will work hand in hand with global partners to
provide users with more competitive products and better health
solutions."
During the conference, Yuwell Medical and the American company
Inogen formalized their collaboration by signing a strategic
investment and cooperation memorandum, further deepening their
partnership in the respiratory segment.
As one of the world's largest manufacturers of oxygen
concentrators, Yuwell Medical is widely recognized for its
strong R&D capabilities and advanced manufacturing
capabilities.
Inogen, a leading U.S. manufacturer of oxygen concentrators,
brings extensive experience in portable oxygen concentrator
technology. Yuwell, through its whole-owned subsidiary Yuwell
(Hong Kong) Holdings Limited, has
agreed to invest approximately $27.2
million in Inogen, representing 9.9% of the outstanding
shares of Inogen's common stock upon closing of this
investment.
The two companies seek to upgrade devices technology through
deepened collaboration. By combining their expertise and brand in
their respective industry segments and geographies, Yuwell and
Inogen agree to carry out in-depth strategic cooperation based on
business synergy in four aspects: international distribution
business, trademark licensing and distribution business, joint
research and development, and supply chain optimization.
Yuwell Medical and Inogen are excited to build a long-term
strategic partnership, ready to take advantage of emerging
opportunities in today's market. Together, they aim to enhance
their international competitiveness and deliver innovative products
that improve lives worldwide.
Looking forward, Yuwell Medical will stay focused on
innovation, driving breakthroughs in medical technology, and
working with global partners to shape the future of healthcare.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/arab-health-2025yuwell-medical-announces-strategic-investment-and-partnership-with-inogen-in-respiratory-health-302360434.html
SOURCE Yuwell Medical